Dry Macular Degeneration
6
0
0
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Ssoct Imaging
Research Leaders
15 sponsors active, led by Boston Image Reading Center
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (6)
Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD
Non Exudative AMD Imaged With SS-OCT
Non Exudative AMD Imaged With SS-OCT- Extension
Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD
BioCurrent Electrical Stimulation for the Treatment of Dry ARMD
Study to Assess the Safety and Effects of Cells Injected Intravitreal in Dry Macular Degeneration
Research Network
Common Treatments
- Ssoct Imaging2
- Cpcbrpe11
- Electrical Stimulation Of The Retina1
- Adipose Derived Stem Cells1
- Metformin1
Active Sponsors
- Boston Image Reading Center2
- San Francisco Veterans Affairs Medical Center1
- California Retina Consultants1
- Regenerative Patch Technologies, LLC1
- Northwestern University1
Top Investigators
Boston Image Reading Center/Tufts Medical Center
Bascom Palmer Eye Institute
University of California, San Francisco
Regenerative Patch Technologies
Related Conditions
- Geographic Atrophy2
- Agerelated Macular Degeneration1
- Macular Degeneration Agerelated1